For the past 40 years, Davol has stood out as the market leader in providing solutions in soft tissue reconstruction including products for hernia repair, specialized surgical procedures, fixation and biologic implants.
Now a subsidiary of C. R. Bard, Inc., Davol continues to maintain its leadership position in the medical device industry with an expanded portfolio of proven, innovative solutions. These include a growing line of mesh prosthetics, biologic implants, and fixation systems to complement innovative techniques for inguinal, ventral and other hernia procedures, plus a range of products for laparoscopy, pulsed lavage and wound management. In addition to this extensive suite of products, our BioSurgery franchise is delivering a growing line of enhanced sealants and hemostatic products to complement surgical techniques across, thoracic, cardiovascular and other surgical specialties